Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer

NCT04536220 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-03-29

No results posted yet for this study

Summary

Explore new markers based on portal venous blood sampling to establish novel diagnostic models for identification of malignant pancreatic mass.

Conditions

  • Diagnoses Disease

Interventions

DIAGNOSTIC_TEST

Endoscopic Ultrasound (EUS), Fine Needle Aspiration

Endoscopic Ultrasound (EUS), Fine Needle Aspiration, which are routine clinical operations

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Kaixuan Wang, MD · Changhai Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-07-30
Completion
2026-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04536220 on ClinicalTrials.gov